BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 183923)

  • 1. [Effects of various drugs on human serum ACTH secretion].
    Hashimoto K; Takahara J; Yunoki M; Hosoki H; Ofuji M
    Horumon To Rinsho; 1976; 24(3):221-6. PubMed ID: 183923
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radioimmunoassay of ACTH].
    Matsukura S; Matsuyama H; Nakai Y; Imura H
    Saishin Igaku; 1971 Jun; 26(6):1085-90. PubMed ID: 4329054
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of growth hormone release-inhibiting hormone and bromocryptine (CB 154) in states of abnormal pituitary-adrenal function.
    Benker G; Hackenberg K; Hamburger B; Reinwein D
    Clin Endocrinol (Oxf); 1976 Mar; 5(2):187-90. PubMed ID: 178470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
    Beech J; Boston R; Lindborg S; Russell GE
    J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of plasma ACTH in 100 human lysine-vasopressin tests].
    Binoux M; Gourmelen-Combourieu M; Luton JP; Girard F; Pham-Huu-Trung MT
    Acta Endocrinol (Copenh); 1971 Sep; 68(1):1-30. PubMed ID: 4328565
    [No Abstract]   [Full Text] [Related]  

  • 6. [Radioimmunoassay determination of human plasma ACTH in adrenal and pituitary gland disorders].
    Kosowicz J; Szekalski S; Kozlowski W
    Pol Arch Med Wewn; 1971 Nov; 47(5):527-32. PubMed ID: 4332282
    [No Abstract]   [Full Text] [Related]  

  • 7. TSH and ACTH secretion and cyclic adenosine 3'5' monophosphate content following stimulation with TRH or lysine vasopressin in vitro: suppression by thyroxine and dexamethasone.
    Rose JC; Conklin PM
    Proc Soc Exp Biol Med; 1978 Sep; 158(4):524-9. PubMed ID: 211516
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of plasma growth hormone and ACTH levels in various states of pituitary-adrenal dysfunction].
    Binoux M; Donnadieu M; Combourieu M; Schimpff RM; Girard F; Mozziconacci P
    Ann Pediatr (Paris); 1968 May; 15(5):367-74. PubMed ID: 4299918
    [No Abstract]   [Full Text] [Related]  

  • 9. [Symptomatologic study of plasma ACTH].
    Bobillo ER
    Rev Iber Endocrinol; 1972; 19(111):263-79. PubMed ID: 4338652
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoreactive corticotropin-releasing factor in human plasma.
    Suda T; Tomori N; Yajima F; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K
    J Clin Invest; 1985 Nov; 76(5):2026-9. PubMed ID: 2997301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human plasma immunoreactive lipotropin and adrenocorticotropin in normal subjects and in patients with pituitary-adrenal disease.
    Krieger DT; Liotta AS; Suda T; Goodgold A; Condon E
    J Clin Endocrinol Metab; 1979 Apr; 48(4):566-71. PubMed ID: 219000
    [No Abstract]   [Full Text] [Related]  

  • 12. α-Melanocyte--stimulating hormone and adrenocorticotropin concentrations in response to thyrotropin-releasing hormone and comparison with adrenocorticotropin concentration after domperidone administration in healthy horses and horses with pituitary pars intermedia dysfunction.
    Beech J; McFarlane D; Lindborg S; Sojka JE; Boston RC
    J Am Vet Med Assoc; 2011 May; 238(10):1305-15. PubMed ID: 21568777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functional diagnosis of the hypothalamo-hypophyseal-adrenal system using radioimmunologic ACTH determination].
    Fehm HL; Voigt KH; Pfeiffer EF
    Verh Dtsch Ges Inn Med; 1972; 78():1515-8. PubMed ID: 4353147
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled and nasal corticosteroids: is the early-morning serum adrenocorticotropic hormone (ACTH) a useful screening test?
    Zöllner EW; Lombard C; Galal U; Hough S; Irusen E; Weinberg E
    Pediatr Allergy Immunol; 2011 Sep; 22(6):614-20. PubMed ID: 21797928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal and abnormal regulation of beta-msh in man.
    Abe K; Nicholson WE; Liddle GW; Orth DN; Island DP
    J Clin Invest; 1969 Aug; 48(8):1580-5. PubMed ID: 4307702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid secretion: responses to alpha1-24 corticotropin, metyrapone and dexamethasone.
    Frawley TF
    Trans Am Clin Climatol Assoc; 1972; 83():45-56. PubMed ID: 4339147
    [No Abstract]   [Full Text] [Related]  

  • 17. Melatonin and corticosteroid response to metyrapone in patients with pituitary disease.
    Brismar K; Werner S; Wetterberg L
    Prog Clin Biol Res; 1982; 92():283-92. PubMed ID: 6287497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Size heterogeneity of immunoreactive human ACTH in plasma and in extracts of pituitary glands and ACTH-producing thymoma.
    Yalow RS; Berson SA
    Biochem Biophys Res Commun; 1971 Jul; 44(2):439-45. PubMed ID: 4334140
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory effect of prepro-thyrotrophin-releasing hormone (178-199) on adrenocorticotrophic hormone secretion by human corticotroph tumours.
    Pecori Giraldi F; Pesce S; Maroni P; Pagliardini L; Lasio G; Losa M; Cavagnini F
    J Neuroendocrinol; 2010 Apr; 22(4):294-300. PubMed ID: 20136686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of metyrapone on corticotrophin secretion.
    Donald RA; Espiner EA; Beaven DW
    J Endocrinol; 1972 Mar; 52(3):517-24. PubMed ID: 4336119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.